Novartis Pharmaceuticals Uk Ltd
FRIMLEY, England, January 13, 2011 - Novartis Pharmaceuticals UK Ltd today announced that
Lucentis(R) (ranibizumab) is being launched in the UK for the treatment of
visual impairment due to diabetes, specifically diabetic macular oedema
(DMO).
